Skip to main content
SpringerLink
Log in

β-Blocker Plasma Concentrations and Inflammatory Disease

Clinical Implications

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Aronson, K.-F.; Ekelund, G.; Kindmark, C.-O. and Laurell, C.-B.: Sequential changes of plasma proteins after surgical trauma. Scandinavian Journal of Clinical Laboratory Investigation 29 (Suppl. 124): 127–136 (1972).

    Article  Google Scholar 

  • Bishop, H.; Schneider, R.E. and Welling, P.G.: Plasma propranolol concentrations in rats with adjuvant-induced arthritis. Biopharmaceutics and Drug Disposition 2: 291–297 (1981).

    Article  CAS  Google Scholar 

  • Branch, R.A.; Kornhauser, D.M.; Shand, D.G.; Wilkinson, G.R. and Wood, A.J.J.: Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis. British Journal of Clinical Pharmacology 4: 630P (1977).

    Article  Google Scholar 

  • Brodie, B.B. and Reid, W.D.: The value of determining the plasma concentration of drugs in animals and man; in La Du et al. (Eds) Fundamentals of Drug Metabolism and Drug Disposition, pp.328–339 (Williams and Wilkins Company, Baltimore, Maryland 1972).

    Google Scholar 

  • DeLeve, L.D. and Piafsky, K.M.: Clinical significance of plasma binding of basic drugs. Trends in Pharmacological Sciences 2: 283–284 (1981).

    Article  CAS  Google Scholar 

  • Feely, J.; Forrest, A.; Gunn, A.; Hamilton, W.; Stevenson, I. and Crooks, J.: Influence of surgery on plasma propranolol levels and protein binding. Clinical Pharmacology and Therapeutics 28: 759–764 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Fremstad, D.; Bergerud, K.; Haffner, J.F.W. and Lunde, P.K.M.: Increased binding of quinidine after surgery: A preliminary report. European Journal of Clinical Pharmacology 10: 441–444 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Johansson, B.G.; Kindmark, C.-O.; Trell, E.Y. and Wollheim, F.A.: Sequential changes of plasma proteins after myocardial infarction. Scandinavian Journal of Clinical Laboratory Investigation 29 (Suppl. 124): 117–126 (1972).

    Article  Google Scholar 

  • Piafsky, K.M.: Disease-induced changes in the plasma binding of basic drugs. Clinical Pharmacokinetics 5: 246–262 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Piafsky, K.M.; Borgå, O.; Oldar-Cederlöf, I.; Johansson, C. and Sjöqvist, F.: Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma α2-acid glycoprotein. New England Journal of Medicine 299: 1435–1439 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Routledge, P.A.; Stargel, W.W.; Wagner, G.S. and Shand, D.G.: Increased plasma propranolol binding in myocardial infarction. British Journal of Clinical Pharmacology 9: 438–440 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Routledge, P.A.; Shand, D.G.; Barchowsky, A.; Wagner, G. and Stargel, W.W.: Relationship between α1-acid glycoprotein and lidocaine disposition in myocardial infarction. Clinical Pharmacology and Therapeutics 30: 154–157 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Sager, G.; Nilsen, O.G. and Jacobsen, S.: Variable binding of propranolol in human serum. Biochemical Pharmacology 28: 905–911 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Sager, G.; Hansteen, V.; Aakesson, I. and Jacobsen, S.: Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction. British Journal of Clinical Pharmacology 12: 613–620 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Scott, B.J.; Bradwell, A.R.; Schneider, R.E. and Bishop, H.: Propranolol binding to serum orosomucoid. Lancet 1: 930 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Schneider, R.E.; Babb, J.; Bishop, H.; Mitchard, M.; Hoare, A.M. and Hawkins, C.F.: Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn’s disease. British Medical Journal 2: 794–795 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Schneider, R.E.; Bishop, H. and Hawkins, C.F.: Plasma propranoloi concentrations and the erythrocyte sedimentation rate. British Journal of Clinical Pharmacology 8: 43–47 (1979a).

    Article  PubMed  CAS  Google Scholar 

  • Schneider, R.E.; Bishop, H.; Hawkins, C.F. and Kitis, G.: Drug binding to α1-glycoprotein. Lancet 1: 554 (1979b).

    Article  PubMed  CAS  Google Scholar 

  • Schneider, R.E.; Bishop, H.; Kendall, M.J. and Quarterman, C.P.: Effect of inflammatory disease on plasma concentrations of three β-adrenoceptor blocking agents. International Journal of Clinical Pharmacology, Therapy and Toxicology 19: 158–162 (1981).

    CAS  Google Scholar 

  • Serlin, M.J.; Orme, M.L’E.; Baber, N.S.; Sibeon, R.G.; Laws, E. and Breckenridge, A.: Propranoloi in the control of blood pressure: A dose-response study. Clinical Pharmacology and Therapeutics 27: 586–592 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Shand, D.G.: Individualization of propranolol therapy. Medical Clinics of North America 58: 1063–1069 (1974).

    PubMed  CAS  Google Scholar 

  • Snyder, S.; Durham, B.C.; Iskandrian, A.S.; Coodley, E.L. and Linhart, J.W.: Serum lipids and glycoproteins in acute myocardial infarction. American Heart Journal 90: 582–586 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Whitehouse, M.W. and Beck, F.J.: Impaired drug metabolism in rats with adjuvant induced arthritis: A brief review. Drug Metabolism and Disposition 1: 251–255 (1973).

    PubMed  CAS  Google Scholar 

  • Wilkinson, G.R. and Shand, D.G.: A physiological approach to drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390 (1975).

    PubMed  CAS  Google Scholar 

  • Wood, M. and Wood, A.J.J.: Changes in plasma drug binding and α1-acid glycoprotein in mother and new-born infant. Clinical Pharmacology and Therapeutics 29: 522–526 (1981).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Therapeutics and Clinical Pharmacology, Medical School, University of Birmingham, Birmingham, UK

    R. E. Schneider & H. Bishop

Authors
  1. R. E. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Bishop
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneider, R.E., Bishop, H. β-Blocker Plasma Concentrations and Inflammatory Disease. Clin Pharmacokinet 7, 281–284 (1982). https://doi.org/10.2165/00003088-198207040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198207040-00001

Keywords

Search

Navigation